TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Immunity

• Publication date

  2001-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1074-7613(01)00183-2PMID 11520463
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cutting Edge: A Role for B Lymphocyte Stimulator in Systemic Lupus Erythematosus1

  2001cited by this paper
• Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

  2001cited by this paper
• Cutting Edge Commentary: Origins of B-1 Cells1 2

  2001cited by this paper
• B cell development pathways.

  2001cited by this paper
• The 3.2-Å crystal structure of the human IgG1 Fc fragment–FcγRIII complex

  2000cited by this paper
• TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

  2000cited by this paper
• Baff Mediates Survival of Peripheral Immature B Lymphocytes

  2000cited by this paper
• Baff Binds to the Tumor Necrosis Factor Receptor–Like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell Population

  2000cited by this paper
• APRIL and TALL-1 and receptors BCMA and TACI: system for regulating humoral immunity

  2000cited by this paper
• Making smarter immunotherapies

  2000cited by this paper
• The IgG Fc contains distinct Fc receptor (FcR) binding sites: the leukocyte receptors Fc gamma RI and Fc gamma RIIa bind to a region in the Fc distinct from that recognized by neonatal FcR and protein A.

  2000cited by this paper
• Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI.

  2000cited by this paper
• April and Baff Connect Autoimmunity and Cancer

  2000cited by this paper
• Development and function of B-1 cells.

  2000cited by this paper
• B‐cell subsets and the mature ­preimmune repertoire. Marginal zone and B1 B cells as part of a “natural immune memory”

  2000cited by this paper
• Knock‐out mouse for Canavan disease: a model for gene transfer to the central nervous system

  2000cited by this paper
• A Soluble Form of B Cell Maturation Antigen, a Receptor for the Tumor Necrosis Factor Family Member April, Inhibits Tumor Cell Growth

  2000cited by this paper
• Attenuation of Apoptosis Underlies B Lymphocyte Stimulator Enhancement of Humoral Immune Response

  2000cited by this paper
• Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity

  2000cited by this paper
• The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex.

  2000cited by this paper
• Tumor Necrosis Factor (TNF) Receptor Superfamily Member TACI Is a High Affinity Receptor for TNF Family Members APRIL and BLyS*

  2000cited by this paper
• Immunology. Lymphocyte survival--ignorance is BLys.

  2000cited by this paper
• Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk.

  2000cited by this paper
• Signaling through the B cell antigen receptor in developing B cells.

  2000cited by this paper
• Taci is expressed on a subset of human b-lymphomas and may enhance tumor survival

  2000cited by this paper
• The IgG Fc Contains Distinct Fc Receptor (FcR) Binding Sites: The Leukocyte Receptors FcγRI and FcγRIIa Bind to a Region in the Fc Distinct from That Recognized by Neonatal FcR and Protein A1

  2000cited by this paper
• Lymphocyte Survival--Ignorance Is BLys

  2000cited by this paper
• Construction of Gene Targeting Vectors from λKOS Genomic Libraries

  1999cited by this paper
• BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator.

  1999cited by this paper
• Construction of gene targeting vectors from lambda KOS genomic libraries.

  1999cited by this paper
• BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth

  1999cited by this paper
• B Cell Development in the Spleen Takes Place in Discrete Steps and Is Determined by the Quality of B Cell Receptor–Derived Signals

  1999cited by this paper
• Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations

  1999cited by this paper
• A role for B cells in the development of T cell helper function in a malaria infection in mice.

  1998cited by this paper
• The characterization of murine BCMA gene defines it as a new member of the tumor necrosis factor receptor superfamily.

  1998cited by this paper
• APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth

  1998cited by this paper
• B cell‐deficient mice do not develop type II collagen‐induced arthritis (CIA)

  1998cited by this paper
• Evidence for an Underlying CD4 Helper and CD8 T-Cell Defect in B-Cell-Deficient Mice: Failure To Clear Persistent Virus Infection after Adoptive Immunotherapy with Virus-Specific Memory Cells from μMT/μMT Mice

  1998cited by this paper
• Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses

  1997cited by this paper
• NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily.

  1997cited by this paper
• The complexity of signaling pathways activated by the BCR.

  1997cited by this paper
• B Lymphocyte Developmental Lineages

  1997cited by this paper
• Aberrant B Cell Development and Immune Response in Mice with a Compromised BCR Complex

  1996cited by this paper
• Positive and negative selection events during B lymphopoiesis.

  1995cited by this paper
• Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk

  1995cited by this paper
• Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression

  1994cited by this paper
• Distinctive Developmental Origins and Specificities of Murine CD5+ B Cells

  1994cited by this paper
• Structural features of human immunoglobulin G that determine isotype- specific differences in complement activation

  1993cited by this paper
• The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region

  1991cited by this paper
• Localization of the binding site for the human high-affinity Fc receptor on IgG

  1988cited by this paper
• Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells.

  1987cited by this paper
• B-cell subpopulations identified by two-colour fluorescence analysis

  1982cited by this paper

• New biological agents in systemic lupus erythematosus.

  2026cites this paper
• Neutrophils as critical orchestrators of chronic inflammation

  2026cites this paper
• The multilayered identity of B cell memory

  2026cites this paper
• BAFF in autoimmune kidney diseases: pathogenic pathways, biomarker potential, and therapeutic horizons

  2025cites this paper
• Novel therapies for myasthenia gravis: Translational research from animal models to clinical application

  2025cites this paper
• Cytokine pathways driving diverse tissue pathologies in rheumatoid arthritis.

  2025cites this paper
• Integrative miRNA-mRNA profiling uncovers mechanisms of belimumab action in systemic lupus erythematosus

  2025cites this paper
• The role of B cell-activating factor system in autoimmune diseases: mechanisms, disease implications, and therapeutic advances

  2025cites this paper
• T cell Dissimilarities in B Cell Activating Factor–Deficient Versus B Cell Activating Factor Receptor 3–Deficient Systemic Lupus Erythematosus‐Prone NZM 2328 Mice as Contributors to Their Divergent Clinical Outcomes

  2024cites this paper
• Exploring the depths of IgG4: insights into autoimmunity and novel treatments

  2024cites this paper
• PD-1 antibody interactions with Fc gamma receptors enable PD-1 agonism to inhibit T cell activation - therapeutic implications for autoimmunity.

  2024cites this paper
• Germline mutations in cancer predisposition genes among pediatric patients with cancer and congenital anomalies

  2024cites this paper
• Past and present discovery of the BAFF/APRIL system - A bibliometric study from 1999 to 2023.

  2024cites this paper
• Contributions of each of the BAFF receptors to the lymphocyte profiles in C57BL/6 mice

  2024cites this paper
• The emerging role of BLyS/APRIL in autoimmune diseases: Biological characteristics, functions, and therapeutic potential.

  2024cites this paper
• Serum BAFF levels are associated with the prognosis of idiopathic membranous nephropathy

  2024cites this paper
• Immunization-induced Establishment and Serum Expression of BAFF/Gd-IgA1 in IgAN Rats

  2024cites this paper
• TACI Ig Fusion Protein Inhibits TLR4/MyD88/NF-κB Pathway Alleviates Renal Injury in IgA Nephropathy Rats.

  2024cites this paper
• The role of immunoglobins in atherosclerosis development; friends or foe?

  2024cites this paper
• Current status of BAFF targeting immunotherapy in B-cell neoplasm

  2024cites this paper
• Role of cellular effectors in the induction and maintenance of IgA responses leading to protective immunity against enteric bacterial pathogens

  2024cites this paper
• Engineering antigen-presenting cells for immunotherapy of autoimmunity.

  2024cites this paper
• Single-cell analysis of human prepuce reveals dynamic changes in gene regulation and cellular communications

  2023cites this paper
• Povetacicept, an Enhanced Dual APRIL/BAFF Antagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell–Related Autoimmune Diseases

  2023cites this paper
• Impact of IgG subclass on monoclonal antibody developability

  2023cites this paper
• Prognostic costimulatory molecule-related signature risk model correlates with immunotherapy response in colon cancer

  2023cites this paper
• The BAFF-APRIL System in Cancer

  2023cites this paper
• Single-cell and bulk RNA sequencing analysis of B cell marker genes in TNBC TME landscape and immunotherapy

  2023cites this paper
• Blockade of BLyS inhibits B cell responses and antibody production for the prevention of chronic transplant rejection.

  2023cites this paper
• Identifying lupus Patient Subsets Through Immune Cell Deconvolution of Gene Expression Data in Two Atacicept Phase II Studies

  2023cites this paper
• Comprehensive analysis of the correlation between GSTM1 and tumor immunity in colon cancer

  2022cites this paper
• Comprehensive Molecular Analyses of a TNF Family-Based Gene Signature as a Potentially Novel Prognostic Biomarker for Cervical Cancer

  2022cites this paper
• TNFRSF13B is a potential contributor to prostate cancer

  2022cites this paper
• B Cell and T Cell Dissimilarities in BAFF-Deficient versus BR3-Deficient C57BL/6 Mice.

  2022cites this paper
• Gene Therapy for Sjögren’s Syndrome

  2021cites this paper
• Immunosuppression in Multiple Sclerosis and Other Neurologic Disorders.

  2021cites this paper
• BVVL / FL : Features caused by SLC 52 A 3 mutations ; WDFY 4 and TNFSF 13 B may be 1 novel causative genes 2

  2021cites this paper
• An Overview of CAR T Cell Mediated B Cell Maturation Antigen Therapy.

  2021cites this paper
• B cell-activating factor and its targeted therapy in autoimmune diseases.

  2021cites this paper
• Telitacicept as a BLyS/APRIL dual inhibitor for autoimmune disease

  2021cites this paper
• Receptor Interacting Protein Kinase Pathways Regulate Innate B Cell Developmental Checkpoints But Not Effector Function in Mice

  2021cites this paper
• B cell–activating factor modulates the factor VIII immune response in hemophilia A

  2021cites this paper
• BAFF signaling in health and disease.

  2021cites this paper
• Meant to B: B cells as a therapeutic target in systemic lupus erythematosus.

  2021cites this paper
• Impact of IgG subclass on molecular properties of monoclonal antibodies

  2021cites this paper
• Sequencing at lymphoid neoplasm susceptibility loci maps six myeloma risk genes

  2021cites this paper
• Silencing and activating anergic B cells *

  2021cites this paper
• CNS Autoimmune Responses in BCMA-Deficient Mice Provide Insight for the Failure of Atacicept in MS

  2021cites this paper
• Memory B Cells in Multiple Sclerosis: Emerging Players in Disease Pathogenesis

  2021cites this paper
• Review article: targeting the B cell activation system in autoimmune hepatitis

  2021cites this paper
• B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies

  2021cites this paper
• BAFF-driven NLRP3 inflammasome activation in B cells

  2020cites this paper
• BAFFR controls early memory B cell responses but is dispensable for germinal center function

  2020cites this paper
• Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinoma

  2020cites this paper
• BAFF attenuates oxidative stress-induced cell death by the regulation of mitochondria membrane potential via Syk activation in WiL2-NS B lymphoblasts

  2020cites this paper
• Transmembrane Activator and CAML Interactor (TACI): Another Potential Target for Immunotherapy of Multiple Myeloma?

  2020cites this paper
• Inhibition of B cell activation following in vivo co-engagement of B cell antigen receptor and Fcγ receptor IIb in non-autoimmune-prone and SLE-prone mice

  2020cites this paper
• B Cell Receptor Signaling.

  2020cites this paper
• Regulation of tumor necrosis superfamily molecules, BAFF and APRIL, in response to pathogenic exposure and ligand stimulation in freshwater carp, Catla catla

  2020cites this paper
• Transitional B cells involved in autoimmunity and their impact on neuroimmunological diseases

  2020cites this paper
• Promotion of T Regulatory Cells in Mice by B Cells and BAFF

  2020cites this paper
• Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma

  2020cites this paper
• Development of Murine Systemic Lupus Erythematosus in the Absence of BAFF

  2020cites this paper
• A proliferation-inducing ligand (APRIL); autoimmunity; B cell activating factor of the tumour necrosis factor (TNF) family (BAFF); innate immunity; interferon (IFN); systemic lupus erythematosus (SLE)

  2020cites this paper
• Suppressed humoral immunity is associated with dengue nonstructural protein NS1-elicited anti-death receptor antibody fractions in mice

  2020cites this paper
• Defective circulating and intrahepatic B cells in chronic HBV

  2019cites this paper
• Serum Levels of BAFF and APRIL Predict Clinical Response in Anti-PLA2R-Positive Primary Membranous Nephropathy

  2019cites this paper
• APRIL/BLyS Blockade Reduces Donor-specific Antibodies in Allosensitized Mice.

  2019cites this paper
• BAFF inhibition in SLE—Is tolerance restored?

  2019cites this paper
• Autoantibody production significantly decreased with APRIL/BLyS blockade in murine chronic rejection kidney transplant model

  2019cites this paper
• A proliferation inducing ligand (APRIL), une molécule, deux fonctions opposées dans l'autoimmunité

  2019cites this paper
• The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond.

  2019cites this paper
• Synovial tissues concentrate secreted APRIL GABAY , Cem

  2019cites this paper
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Atacicept in a Randomized Trial in Healthy Caucasian and Japanese Subjects

  2019cites this paper
• From zero to sixty and back to zero again: the metabolic life of B cells.

  2019cites this paper
• Desensitization and treatment with APRIL/BLyS blockade in rodent kidney transplant model

  2019cites this paper
• The role of BAFF and APRIL in rheumatoid arthritis

  2019cites this paper
• Ocrelizumab: A New Generation of anti‐CD20 mAbfor Treatment of Multiple Sclerosis

  2019cites this paper
• Regulation of IgM+ B Cell Activities by Rainbow Trout APRIL Reveals Specific Effects of This Cytokine in Lower Vertebrates

  2018cites this paper
• Macrophage Depletion as a Therapeutic Method After SCI

  2018cites this paper
• Novel Insights on the Regulation of B Cell Functionality by Members of the Tumor Necrosis Factor Superfamily in Jawed Fish

  2018cites this paper
• BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus

  2018cites this paper
• Increased B cell activating factor is associated with B cell class switching in patients with tuberculous pleural effusion.

  2018cites this paper
• Common Variable Immunodeficiency and Gastric Malignancies

  2018cites this paper
• BAFF and BAFF-Receptor in B Cell Selection and Survival

  2018cites this paper
• Signalling for B cell survival.

  2018cites this paper
• Inhibition of Membrane-Bound BAFF by the Anti-BAFF Antibody Belimumab

  2018cites this paper
• The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting.

  2018cites this paper
• IKKα deficiency disrupts the development of marginal zone and follicular B cells

  2018cites this paper
• Estudio del estado de maduración del linfocito b y factores solubles asociados a rechazo e infección en pacientes sometidos a transplante de órgano sólido

  2018cites this paper
• ResponsesImpacts HIV Env-Induced Antibody BLyS-Mediated Modulation of Naive B Cell

  2017cites this paper
• BAFF- and TACI-Dependent Processing of BAFFR by ADAM Proteases Regulates the Survival of B Cells.

  2017cites this paper
• Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases

  2017cites this paper
• Rôle de la molécule APRIL dans le développement des hémopathies malignes B

  2017cites this paper
• B cell activating factor (BAFF) selects IL‐10−B cells over IL‐10+B cells during inflammatory responses

  2017cites this paper
• Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosis.

  2017cites this paper
• Immune-Mediated Accelerated Atherosclerosis

  2017cites this paper
• Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies In Vivo

  2017cites this paper
• Inhibition of B cell activating factor (BAFF) in the management of systemic lupus erythematosus (SLE)

  2017cites this paper
• The Role of BAFF System Molecules in Host Response to Pathogens

  2017cites this paper